Multidrug-resistant tuberculosis and short 9-month treatment regimen:
45,90 €*
Sofort verfügbar, Lieferzeit: 1-3 Tage
Produktnummer:
9786203983234
This is a retrospective study conducted over a period of 4 years from 2013-2016. The overall objective was to analyze the epidemiological, therapeutic and evolutionary aspects of diagnosed multidrug-resistant tuberculosis cases treated with the short 9-month treatment regimen. 190 multidrug-resistant tuberculosis patients were collected during the study period. They had an average age of 35.12 years with extremes of 3 to 79 years, the most affected age group was between 21 and 40 years. They were predominantly male (67.36%) and lived mostly in low socio-economic neighbourhoods of Bujumbura. 85.26% of them had a history of antituberculosis treatment and 23.68% had a TB-HIV co-infection known to worsen the prognosis. The largest proportion (95.26%) followed a standardised second-line treatment regimen of 9 months and the evolution was favourable with 93.68% cases of cure, 4.74% cases of death, 1.05% cases lost to follow-up and 0.53% cases of therapeutic failure.Keywords:MDR-TB,epidemiology, short 9 months treatment regimen, evolution
| Autor: | Sibomana, Thierry Nzisabira, Emile Kamamfu, Gaspard |
|---|---|
| EAN: | 9786203983234 |
| Sprache: | Englisch |
| Seitenzahl: | 80 |
| Produktart: | kartoniert, broschiert |
| Verlag: | Our Knowledge Publishing |
| Untertitel: | Epidemiological, therapeutic and evolutionary analysis of treated cases. Case of Burundi |
| Schlagworte: | Evolution Epidemiology short 9-month treatment regimen MDR-TB |
| Größe: | 150 × 220 |
